Compare Peloton Interactive Inc (PTON) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Peloton Interactive Inc vs Tenet Healthcare Corporation — how do they compare? Peloton Interactive Inc trades at $4.92 (market cap $2.16B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 9.7× Peloton Interactive Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Peloton Interactive Inc for 37 Days and Tenet Healthcare Corporation for 15 Days on average.
| PTON | THC | |
|---|---|---|
Market Cap | $2.16B | $20.98B |
Volume | 11,369,487 | 428,008 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.86 | $280.77 |
52-Week Low | $3.71 | $161.37 |
Typical Hold Time | 37 Days | 15 Days |
Enterprise Value | $2.66B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Peloton (PTON) trades at $4.85, down 0.41% on the day, as the stock remains under technical pressure with bearish moving average signals. Fundamentally, the company achieved its first full-year net profit in fiscal 2026 with a 2.58% margin, while revenue declined to $2.4B. Recent product launches include a new foldable Tread Flex treadmill and AI-powered coaching features, signaling continued turnaround efforts under CEO Peter Stern's leadership.
The outlook remains challenged despite profitability improvements, with analyst consensus pointing to significant upside (target $8.00) but technical weakness and declining subscriber counts creating headwinds. Key risks include execution of the turnaround strategy, competitive pressure in connected fitness, and high debt levels, though cost-cutting measures show early success.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
